Vornado Realty Trust (0LR2)
London Stock Exchange · UK · prices in USD · close of 28 Oct 2026
Key indicators
| Last close | USD 34.24 |
|---|---|
| 52-week range | 24.93 – 41.54 |
| Return, 1 month / 3 months | +0.4% / −13.2% |
| Return, 1 year / 3 years | −12.0% / +83.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 34.9% |
| Worst drawdown (1 year) | -38.1% |
| Average daily value traded | 0.01M USD |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vornado Realty Trust is a real estate investment trust that owns and operates commercial property, chiefly office buildings and street-level retail space concentrated in New York City. Its customers are businesses and retailers that lease space in its buildings, and it also holds interests in other real estate assets. The trust is based in New York and manages its properties directly, collecting rent from tenants across its office and retail portfolio.
Vornado Realty Trust trades under the code 0LR2 on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vornado Realty Trust (0LR2) trades on the London Stock Exchange in UK. It last closed at USD 34.24 on 28 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,504 of 3,790 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.0% and over the last three months it fell 13.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -17.6% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.2% | ||
| 6-month return | 13.9% | ||
| 12-month return, skipping the last month | -12.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.1% | ||
| Liquidity | 13 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +0.4% |
| 3 months | −13.2% |
| 6 months | +13.9% |
| 1 year | −12.0% |
| 3 years | +83.3% |
| 5 years | −10.3% |
Signals
| 50-day / 200-day average | 36.08 / 33.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Dec 2025 | USD 0.7400 |
| 16 Dec 2024 | USD 0.7400 |
| 14 Dec 2023 | USD 0.3000 |
| 27 Jan 2023 | USD 0.3750 |
| 4 Nov 2022 | USD 0.5300 |
| 5 Aug 2022 | USD 0.5300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.